Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Mulé

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Annals of the New York Academy of Sciences|September 23, 2009
Dendritic cell-based vaccines for pancreatic cancer and melanomaJames J Mulé
Blood Cells, Molecules & Diseases|July 10, 2003
Enhancing dendritic cell-based vaccines by gene modificationAlicia Terando, James J Mulé
The Journal of Clinical Investigation|February 3, 2007
To ablate or not to ablate? HSCs in the T cell driver's seatClaudio Anasetti, James J Mulé
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunityRana Falahat, James J Mulé
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Ectopic lymph nodes within human solid tumorsDomenico Coppola, James J Mulé
Cancer Immunology, Immunotherapy : CII|September 5, 2003
On combining antineoplastic drugs with tumor vaccinesAlicia Terando, James J Mulé
The Journal of Clinical Investigation|July 18, 2002
Making room for T cellsGabriel N Maine, James J Mulé
Nature Medicine|November 2, 2004
Translation of cancer immunotherapiesJames J Mulé, Jeffrey S Weber
Cancer Immunology Research|August 6, 2015
Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune ResponseMartin C Mihm, James J Mulé
Nature Biotechnology|January 10, 2015
Cancer immunotherapy meets biomaterialsJeffrey S Weber, James J Mulé
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Annals of the New York Academy of Sciences|September 23, 2009
Dendritic cell-based vaccines for pancreatic cancer and melanomaJames J Mulé
Blood Cells, Molecules & Diseases|July 10, 2003
Enhancing dendritic cell-based vaccines by gene modificationAlicia Terando, James J Mulé
The Journal of Clinical Investigation|February 3, 2007
To ablate or not to ablate? HSCs in the T cell driver's seatClaudio Anasetti, James J Mulé
Proceedings of the National Academy of Sciences of the United States of America|November 3, 2025
Chemokine/cytokine-releasing biomaterials induce in situ tertiary lymphoid-like structures and enhance antitumor immunityRana Falahat, James J Mulé
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2008
Ectopic lymph nodes within human solid tumorsDomenico Coppola, James J Mulé
Cancer Immunology, Immunotherapy : CII|September 5, 2003
On combining antineoplastic drugs with tumor vaccinesAlicia Terando, James J Mulé
The Journal of Clinical Investigation|July 18, 2002
Making room for T cellsGabriel N Maine, James J Mulé
Nature Medicine|November 2, 2004
Translation of cancer immunotherapiesJames J Mulé, Jeffrey S Weber
Cancer Immunology Research|August 6, 2015
Reflections on the Histopathology of Tumor-Infiltrating Lymphocytes in Melanoma and the Host Immune ResponseMartin C Mihm, James J Mulé
Nature Biotechnology|January 10, 2015
Cancer immunotherapy meets biomaterialsJeffrey S Weber, James J Mulé
Pageof 9